Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas
Article first published online: 30 JAN 2013
© 2012 American Cancer Society
Volume 121, Issue 7, pages 361–369, July 2013
How to Cite
Khode, R., Larsen, D. A., Culbreath, B. C., Parrish, S., Walker, K. L., Sayage-Rabie, L., Beissner, R. S. and Rao, A. (2013), Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas. Cancer Cytopathology, 121: 361–369. doi: 10.1002/cncy.21273
- Issue published online: 12 JUL 2013
- Article first published online: 30 JAN 2013
- Manuscript Accepted: 29 NOV 2012
- Manuscript Revised: 9 NOV 2012
- Manuscript Received: 17 AUG 2012
- 1Centers for Disease Control and Prevention.Lung Cancer Statistics 2008.Atlanta, GA:2008. Available at: http://www.cdc.gov/cancer/lung/statistics/. Accessed November 5, 2012.
- 12American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol. 2011;29:2121-2127., , , et al.
- 23Arcturus Bioscience, Inc.Arcturus PicoPure DNA Extraction Kit handbook.Mountain View, CA:Arcturus Bioscience, Inc.;2012. Available at: http://search.cosmobio.co.jp/cosmo_search_p/search_gate2/docs/MOD_/KIT0103.20090123.pdf. Accessed July 10, 2012.
- 24Zymo Research Corporation.Pinpoint Slide DNA Isolation System Instructions. Catalog no. D3001.Irvine, CA:Zymo Research Corporation;2012. Available at: http://www.zymoresearch.com/media/downloads/16/D3001i.pdf. Accessed July 10, 2012.
- 25Qiagen.EGFR Pyro Handbook.Valencia, CA:Qiagen;2012. Available at: http://www.qiagen.com/selectlocation.aspx?redirect=%2fliterature%2frender.aspx%3fid%3d200796. Accessed July 10, 2012.
- 26Qiagen.EGFR Rotor-Gene Q PCR Kit Handbook.Valencia, CA:Qiagen;2012. Available at: www.qiagen.com/literature/render.aspx?id=201622. Accessed July 10, 2012.
- 35Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol. 2011;29:2866-2874., , , et al.
- 382012; Geneva, Switzerland. 2012. Available at: http://www.dianasterapeuticas.com/web/pdf/ESMO_Handout_PR.pdf. Accessed July 16, 2012., , , et al. Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue (FFPET) specimens of non-small cell lung cancer (NSCLC). Abstract 120. Paper presented at: European Society of Medical Oncology Third European Lung Cancer Conference; April 18-21,